Entero Healthcare Solutions IPO Details
| IPO Size | 1600 |
| Price Range | ₹1195 to ₹1258 |
| Retail Quota | 10% |
| QIB Quota | 75% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE and BSE |
| Minimum Quantity | 11 |
| Investment (cut-off price) | ₹13,838 |
| Pre IPO Promotor Holding | 77.11% |
| Post IPO Promotor Holding | -- |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Entero Healthcare Solutions IPO Timelines
09/02/2024
Start Date13/02/2024
End Date15/02/2024
Refund Initiation15/02/2024
Credit of Shares to Demat Ac16/02/2024
Listing DateEntero Healthcare Solutions IPO Lot Size
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 11 | ₹13,838 |
| Retail Maximum | 14 | 154 | ₹193,732 |
| S-HNI Minimum | 15 | 165 | ₹207,570 |
| B-HNI Minimum | 72 | 792 | ₹996,336 |
Entero Healthcare Solutions IPO Subscription Status
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 2.28 x | 0.22 x | 1.33 x | 1.25 x | 1.53 x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹1228.70 | ₹1149.55 | ₹1258 | ₹1141 |
Entero Healthcare Solutions IPO Company Financials
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2021 | ₹1783.66 | ₹1794.50 | ₹15.35 |
| FY 2022 | ₹2526.54 | ₹2546.35 | ₹29.43 |
| FY 2023 | ₹3305.72 | ₹3309.40 | ₹11.10 |
About Company
Entero Healthcare Solutions operates as a distributor of healthcare products. They facilitate access for healthcare product manufacturers to pharmacies, hospitals, and clinics across India. The company’s warehouses are spread nationwide and it has a last-mile delivery system. With this, it can provide healthcare products to reach a diverse customer base.
Simultaneously, the pharmacies, hospitals, and clinics they serve gain access to various healthcare products through their distribution network and manufacturer relationships. Entero has established supply partnerships with over 1,900 healthcare product manufacturers, granting them access to more than 64,500 product stock-keeping units.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2018 | Healthcare | Prabhat Agrawal |
Know Before Investing
Entero Healthcare Solutions IPO Strengths
- The company is expected to leverage market consolidation in the fragmented healthcare products distribution market.
- The company is one of the largest and fastest-growing healthcare product distribution platforms in the country.
- It has a track record of inorganic expansion and increased geographic reach, revenues and scale.
- The company runs a differentiated business model offering comprehensive and integrated commercial and supply chain solutions.
- It has a proprietary technology platform.
- Experienced Promoters and professional senior management team.
Entero Healthcare Solutions IPO Risks
- The company has very high working capital requirements.
- It has reported a loss in the past.
- The business can be adversely impacted by competition and industry consolidation.
- Changes in prescription drug pricing could impact the business.
- The company has reported negative cash flows.
- It is subject to operational and logistical risks.
Swot Analysis for Entero Healthcare Solutions IPO
Strengths
Weaknesses
Opportunities
Threats
Contact Details of IXIGO
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/initial_offer/public-issues.html
Company Details
Entero Healthcare Solutions Limited
Plot No. I-35, Building – B
Industrial Area Phase – I
13/7 Mathura Road, Faridabad 121 003
Phone: +91 22-69019100
Email: [email protected]
Website: https://www.enterohealthcare.com/
IPO Registar Details
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/initial_offer/public-issues.html
FAQs
The key objectives of Entero Healthcare Solutions IPO are:
- Repayment/prepayment, in full or part, of certain borrowings availed of by their Company and their Subsidiaries.
- Funding the long term working capital requirements.
- Pursuing inorganic growth initiatives through acquisitions.
ICICI Securities Ltd., Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Jefferies India Pvt. Ltd., Jm Financial Ltd., SBI Capital Markets Ltd. are the book-running lead managers for the Entero Healthcare Solutions IPO.